Cardiology

A 63-year-old female presented to hospital with severe, central, sharp chest pain, exacerbated by deep inspiration and upon lying back. She denied cough, fever, or other systemic symptoms…

Prof Banach explained that current lipid-lowering therapy (LLT) with statins, ezetimibe, and proprotein convertase subtilisin/kexin Type 9 inhibitors…

PH encompasses a heterogeneous group of conditions, including PAH (Group 1), PH due to LHD (Group 2), PH due to lung diseases and/or hypoxia…

Advanced stage heart failure accounts for 1-10% of the overall heart failure population and the prevalence is increasing, in part because of…

Major noncardiac surgery leads to development of one or more heart complications within a year for one in five patients.

SARS-CoV-2 infection in patients with congenital heart disease (CHD) is associated with a low risk of moderate or severe coronavirus disease

The ESC Congress 2020 presented several promising clinical trials that may potentially change our practice in heart failure management.

European and USA treatment guidelines are aligned in their standard recommendation of therapies for symptomatic HFrEF. First-line…